Coloplast
836.4 DKK +0.48%2 investors are following this company
Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Revenue
24.5B
EBIT %
27.64 %
P/E
37.66
Dividend yield-%
2.51 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
COLO B
Daily low / high price
827.8 / 838
DKK
Market cap
190.87B DKK
Turnover
110.72M DKK
Volume
133K
Financial calendar
Interim report
20.08.2024
Annual report
05.11.2024
General meeting
05.12.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Niels Peter Louis-Hansen | 20.7 % | 41.1 % |
Aage og Johanne Louis-Hansens Fond | 11.5 % | 15.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Coloplast expands its Luja™ portfolio with next generation catheter for women
Coloplast udvider Luja™-portefølje med nyt kateter til kvinder
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools